Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H27NO.H3O4P |
| Molecular Weight | 407.4404 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)(O)=O.CC(COC1=C(CC2=CC=CC=C2)C=CC=C1)N3CCCCC3
InChI
InChIKey=MCVUURBOSHQXMK-UHFFFAOYSA-N
InChI=1S/C21H27NO.H3O4P/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19;1-5(2,3)4/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3;(H3,1,2,3,4)
DescriptionSources: http://www.mims.com/hongkong/drug/info/cofrelCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/16297353 and http://www.ncbi.nlm.nih.gov/pubmed/5301345
Sources: http://www.mims.com/hongkong/drug/info/cofrel
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/16297353 and http://www.ncbi.nlm.nih.gov/pubmed/5301345
Benproperine (Cofrel) is a cough suppressant. It is used for symptomatic relief of cough. Cofrel is 2-4 times as potent as codeine in suppressing cough in animals. It acts peripherally by blocking afferent sensory nerve impulses originating from receptors in the lungs and pleura.
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
333 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/12567913/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE, (S)- plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
153 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/12567913/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE, (R)- plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
146.4 ng/mL |
80 mg single, oral dose: 80 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE plasma | Homo sapiens population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
4257 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/12567913/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE, (S)- plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
2010 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/12567913/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE, (R)- plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
5234.31 ng × h/mL |
80 mg single, oral dose: 80 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE plasma | Homo sapiens population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
17 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/12567913/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE, (S)- plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
14 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/12567913/ |
60 mg single, oral dose: 60 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE, (R)- plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
24.7 h |
80 mg single, oral dose: 80 mg route of administration: Oral experiment type: SINGLE co-administered: |
BENPROPERINE plasma | Homo sapiens population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Resonance light scattering study on the interaction of benproperine phosphate with eriochrome blue black R in the presence of sodium dodecylbenzene sulphonate and its analytical application. | 2008-09-19 |
|
| [Nondestructive quantitative analysis of Cofrel medicines by improved partial least squares-NIR spectroscopy]. | 2007-06 |
|
| Identification and quantitative determination of benproperine metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry. | 2006-01-02 |
|
| Identification of some benproperine metabolites in humans and investigation of their antitussive effect. | 2005-12 |
|
| Anti-tussive activity of benproperine enantiomers on citric-acid-induced cough in conscious guinea-pigs. | 2004-02 |
Patents
Sample Use Guides
1 or 2 tablets 3 times daily, according to severity of cough. Tablets should be swallowed whole and not chewed.
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/5301345
10(-5) g/ml of Benproperine (ASA 158/5) caused remarkable reduction of the contraction of the tracheal muscle preparation of a guinea pig caused
by histamine HCl.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m2321
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
3563-76-6
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
SUPERSEDED | |||
|
222-635-4
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
ALTERNATIVE | |||
|
SUB00705MIG
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105910
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
31261
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
167811
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
S831Z48C5W
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
100000085016
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
243-050-0
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
DTXSID10941157
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY | |||
|
19428-14-9
Created by
admin on Mon Mar 31 18:40:01 GMT 2025 , Edited by admin on Mon Mar 31 18:40:01 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD